Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 2 , Pages 335-350, June 2008

Vasopressin analogues in the treatment of hepatorenal syndrome and gastrointestinal haemorrhage

    Prof. Dr.
  • Klaus D. Döhler, PhD (CEO of Curatis Pharma GmbH)

      Affiliations

    • Corresponding Author InformationCorresponding author. Te.: +49 511 5304511; Fax: +49 511 5304510.
    Prof. Dr.
  • Markus Meyer, MD (CEO of FOCUS IP GmbH)

      Affiliations

    • Tel: +49 2131 155 454; Fax: +49 2131 155 394

Curatis Pharma GmbH, Karl-Wiechert-Allee 76, D-30625 Hannover, Germany

Pharma Development Holding GmbH, Stresemannallee 6, D-41460 Neuss, Germany

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6896(08)00004-9

doi:10.1016/j.bpa.2008.02.002

Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 2 , Pages 335-350, June 2008

Article Tools

* Image Usage & Resolution